Cite
Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα
MLA
Ying Sun, et al. “Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα.” Frontiers in Pharmacology, vol. 9, Mar. 2018. EBSCOhost, https://doi.org/10.3389/fphar.2018.00268.
APA
Ying Sun, Yu-jun Tan, Zhan-zhao Lu, Bing-bing Li, Cheng-hong Sun, Tao Li, Li-li Zhao, Zhong Liu, Gui-min Zhang, Jing-chun Yao, & Jie Li. (2018). Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα. Frontiers in Pharmacology, 9. https://doi.org/10.3389/fphar.2018.00268
Chicago
Ying Sun, Yu-jun Tan, Zhan-zhao Lu, Bing-bing Li, Cheng-hong Sun, Tao Li, Li-li Zhao, et al. 2018. “Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα.” Frontiers in Pharmacology 9 (March). doi:10.3389/fphar.2018.00268.